Mastech Digital, Inc. (the 'Company') , a leading provider of Digital Transformation Services, today announced that the Company made an award of non-qualified stock options to purchase up to 702,358 ...
Yamaha Motor Manufacturing Company (YMMC) is pleased to announce that Robert (Bob) Brown has been appointed President, effective December 30, 2024. Bob succeeds Takahiro (Taka) Imanishi, who has ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ ...
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in ...
Shares of TransCode Therapeutics stock opened at $3.85 on Wednesday. The business has a fifty day simple moving average of $395.55 and a 200-day simple moving average of $565.72. TransCode ...
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced ...
BOSTON - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a micro-cap biotech company with a market capitalization of $3.3 million and trading near its 52-week low, has received approval from its Safety ...
TransCode Therapeutics (RNAZ) announced that the Safety Review Committee, or SRC, monitoring its Phase 1 clinical trial has unanimously approved opening of the third cohort of patients based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback